Publication:
Plasma interleukin-1 alpha, interleukin-1 beta and interleukin-1 receptor antagonist levels in pre-eclampsia

dc.contributor.buuauthorKimya, Yalçın
dc.contributor.buuauthorAkdiş, Cezmi
dc.contributor.buuauthorCengiz, Candan
dc.contributor.buuauthorOzan, Hakan
dc.contributor.buuauthorTatlıkazan, Serhat
dc.contributor.buuauthorUncu, Gürkan
dc.contributor.buuauthorŞengül, Ferah
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentKadın Hastalıkları ve Doğum Ana Bilim Dalı
dc.contributor.departmentMikrobiyoloji Ana Bilim Dalı
dc.contributor.researcheridF-4657-2014
dc.date.accessioned2021-07-05T11:26:59Z
dc.date.available2021-07-05T11:26:59Z
dc.date.issued1997
dc.description.abstractThe values of plasma interleukin-1 alpha (IL-1 alpha), interleukin-1 beta (IL-1 beta) and interleukin-l receptor antagonist (IL-1ra) levels were evaluated as the markers of pre-eclampsia in 35 serial plasma samples from ten pregnant women who subsequently developed pre-eclampsia and in 74 plasma samples from 20 uncomplicated pregnancies, retrospectively. No correlation was found between plasma IL-1 alpha, IL-1 beta and IL-1ra levels, liver and renal function tests, thrombocyte and white blood cell counts, proteinuria, measured in all systolic and diastolic blood pressures and gestational weeks. Almost equal levels of IL-1 alpha and IL-1 beta were corresponding groups, but these were too few in number to statistically analyze. IL-1ra values were higher in the pre-eclampsia group than in the uncomplicated pregnancy group, at 20-25 and 31-35 gestational weeks significantly and 26-30 gestational weeks insignificantly and showed an increase during labor in both groups. It was found to have 58% positive predictivity, 100% negative predictivity, 50% specificity and 100% sensitivity at gestational weeks 20-25. According to these results, IL-1ra seems to be considered for its high negative predictivity in the exclusion of the probability of pre-eclampsia development during antenatal visits, but its plasma level is not correlated with the severity of the disease.
dc.identifier.citationKimya, Y. vd. (1997). "Plasma interleukin-1 alpha, interleukin-1 beta and interleukin-1 receptor antagonist levels in pre-eclampsia". European Journal of Obstetrics & Gynecology and Reproductive Biology, 73(1), 17-21.
dc.identifier.endpage21
dc.identifier.issn0301-2115
dc.identifier.issue1
dc.identifier.pubmed9175684
dc.identifier.scopus2-s2.0-0030612776
dc.identifier.startpage17
dc.identifier.urihttps://doi.org/10.1016/S0301-2115(97)02698-5
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0301211597026985
dc.identifier.urihttps://www.ejog.org/article/S0301-2115(97)02698-5/fulltext
dc.identifier.urihttp://hdl.handle.net/11452/21068
dc.identifier.volume73
dc.identifier.wosA1997XA44700004
dc.indexed.scopusScopus
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherElsevier Sci Ireland
dc.relation.journalEuropean Journal of Obstetrics & Gynecology and Reproductive Biology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectObstetrics & gynecology
dc.subjectInterleukin-1 beta
dc.subjectReproductive biology
dc.subjectInterleukin-1 receptor antagonist
dc.subjectPre-eclampsia
dc.subjectPregnancy-induced hypertension
dc.subjectInterleukin-1 alpha
dc.subjectExpression
dc.subjectMacrophages
dc.subjectWomen
dc.subject.wosObstetrics & gynecology
dc.subject.wosReproductive biology
dc.titlePlasma interleukin-1 alpha, interleukin-1 beta and interleukin-1 receptor antagonist levels in pre-eclampsia
dc.typeArticle
dc.wos.quartileQ4 (Reproductive biology)
dc.wos.quartileQ3 (Obstetrics & gynecology)
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Kadın Hastalıkları ve Doğum Ana Bilim Dalı
local.contributor.departmentTıp Fakültesi/Mikrobiyoloji Ana Bilim Dalı
local.indexed.atPubMed
local.indexed.atScopus

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: